Synthesis and cytotoxicity studies of bifunctional hybrids of nitrogen mustards with potential enzymes inhibitors based on melamine framework

References

• He J, Anderson MH, Shi W, Eckert R. Design and activity of a ‘dual-targeted’ antimicrobial peptide. Int J Antimicrob Agents 2009;33:532–537.
   PubMed Web of Science ®Google Scholar
• (a) Feyen F, Cachoux F, Gertsch J, Wartmann M, Altmann KH. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization. Acc Chem Res 2008;41:21–31 ; (b) Hulsman N, Medema JP, Bos C, Jongejan A, Leurs R, Smit MJ, et al. Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin. J Med Chem 2007;50:2424–2431.
   Google Scholar
• for review see (a)Ben Abid F, Gazzah A, Ousbane A, Gutierrez M, Brain E. Les alkylants. Oncologie 2007;9:751–757 ; (b) Di Francesco AM, Hargreaves RH, Wallace TW, Mayalarp SP, Hazrati A, Hartley JA, et al. The abnormal cytotoxicities of 2,5-diaziridinyl-1,4- benzoquinone-3-phenyl esters. Anticancer Drug Des 2000;15:347–359; (c) Vedejs E, Naidu BN, Klapars A, Warner DL, Li VS, Na Y, Kohn H. Synthetic enantiopure aziridinomitosenes: Preparation, reactivity, and DNA alkylation studies. J Am Chem Soc 2003;125:15796–15806 and references cited therein.
   Google Scholar
• Maeda M, Ligo M, Tsuda H, Fujita H, Yonemura Y, Nakagawa K et al. Antimetastatic and antitumor effects of 2,4-diamino-6-(pyridine-4-yl)-1,3,5-triazine (4PyDAT) on the high lung metastatic colon 26 tumor in mice. Anticancer Drug Des 2000;15:217–223.
   Google Scholar
• Paquin I, Raeppel S, Leit S, Gaudette F, Zhou N, Moradei O et al. Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors. Bioorg Med Chem Lett 2008;18:1067–1071.
   Google Scholar
• Riou JF, Guittat L, Mailliet P, Laoui A, Renou E, Petitgenet O et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc Natl Acad Sci usa 2002;99:2672–2677 ; (b) Gomez D, Aouali N, Londono-Vallejo A, Lacroix L, Megnin-Chanet F, Lemarteleur T, et al. Resistance to the short term anti-proliferative activity of the g-quadruplex ligand 12459 Is Associated with telomerase overexpression and telomere capping alteration. J Biol Chem 2003;278:50554–50562.
   PubMed Web of Science ®Google Scholar
• Mandal S, Bérubé G, Asselin E, Mohammad I, Richardson VJ, Gupta A et al. A novel series of potent cytotoxic agents targeting G2/M phase of the cell cycle and demonstrating cell killing by apoptosis in human breast cancer cells. Bioorg Med Chem Lett 2007;17:4955–4960.
   Google Scholar
• Chandra M, Sahay AN, Pandey DS, Tripathi RP, Saxena JK, Reddy VJM, et al. Potential inhibitors of DNA topoisomerase II. Ruthenium (II) polypyridyl and pyridyl azine complexes; potential DNA cleaving agents. J Organomet Chem 2004;689:2256–2267.
   Google Scholar
• Kaminski ZJ, Kolesinska B, Markowicz SW. Synthesis and cytostatic properties of monoterpene derivatives of cyanuric and isocyanuric acids. Acta Pol Pharm 2004;61 Suppl:29–32.
   Google Scholar
• Das K, Clark AD Jr, Lewi PJ, Heeres J, De Jonge MR, Koymans LM et al. Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. j Med Chem 2004;47:2550–2560.
   PubMed Web of Science ®Google Scholar
• Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA et al. A new series of estrogen receptor modulators that display selectivity for estrogen receptor beta. j Med Chem 2002;45:5492–5505.
   PubMed Web of Science ®Google Scholar
• Prade L, Huber R, Bieseler B. Structures of herbicides in complex with their detoxifying enzyme glutathione S-transferase - explanations for the selectivity of the enzyme in plants. Structure 1998;6:1445–1452.
   PubMed Web of Science ®Google Scholar
• Li R, Sirawaraporn R, Chitnumsub P, Sirawaraporn W, Wooden J, Athappilly F et al. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs. j Mol Biol 2000;295:307–323.
   PubMed Web of Science ®Google Scholar
• Lancaster CR, Michel H. Refined crystal structures of reaction centres from Rhodopseudomonas viridis in complexes with the herbicide atrazine and two chiral atrazine derivatives also lead to a new model of the bound carotenoid. j Mol Biol 1999;286:883–898.
   Google Scholar
• Kim YJ, Sackett DL, Schapira M, Walsh DP, Min J, Pannell LK et al. Identification of 12Cysbeta on tubulin as the binding site of tubulyzine. Bioorg Med Chem 2006;14:1169–1175.
   PubMed Web of Science ®Google Scholar
• Verheijen JC, Richard DJ, Curran K, Kaplan J, Yu K, Zask A. 2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines as highly potent and selective ATP competitive mTOR inhibitors: optimization of human microsomal stability. Bioorg Med Chem Lett 2010;20:2648–2653 ; (b) Venkatesan AM, Dehnhardt CM, Santos ED, Chen Z, Dos Santos, O, Ayral-Kaloustian S, et al. Bis(morpholino-1,3,5-triazine) derivatives: Potent adenosine 50-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: Discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor. J Med Chem 2010;53:2636–2645.
   PubMed Web of Science ®Google Scholar
• Retailleau P, Colloc’h N, Vivarès D, Bonneté F, Castro B, El-Hajji M et al. Complexed and ligand-free high-resolution structures of urate oxidase (Uox) from Aspergillus flavus: a reassignment of the active-site binding mode. Acta Crystallogr d Biol Crystallogr 2004;60:453–462.
   Google Scholar
• Kumar R, Gupta L, Pal P, Khan S, Singh N, Katiyar SB et al. Synthesis and cytotoxicity evaluation of (tetrahydro-beta-carboline)-1,3,5-triazine hybrids as anticancer agents. Eur J Med Chem 2010;45:2265–2276.
   PubMed Web of Science ®Google Scholar
• Moreau D, Jacquot C, Tsita P, Chinou I, Tomasoni C, Juge M et al. Original triazine inductor of new specific molecular targets, with antitumor activity against nonsmall cell lung cancer. Int J Cancer 2008;123:2676–2683.
   Google Scholar
• Nieto Y. DNA-binding agents. Cancer Chemother Biol Response Modif 2005;22:163–203.
   Google Scholar
• Kaldor JM, Day NE, Hemminki K. Quantifying the carcinogenicity of antineoplastic drugs. Eur J Cancer Clin Oncol 1988;24:703–711.
   PubMedGoogle Scholar
• Kamiński ZJ, Kolesińska B, Kinas R, Jastrza˛bek K, Kolesińska J, The method of manufacturing of trisubstituted triazine derivatives. Pl Pat. Appl P-360–728.
   Google Scholar
• (a) SRB test according to: Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst 1990;82:1107–1112 ; (b) MTT test according to: Marcinkowska E, Kutner A, Radzikowski C. Cell differentiating and anti-proliferative activity of side-chain modified analogues of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 1998;67:71–78.
   Google Scholar
• Petrelli A, Valabrega G. Multitarget drugs: the present and the future of cancer therapy. Expert Opin Pharmacother 2009;10:589–600; (b) Wei D, Jiang X, Zhou L, Chen J, Chen Z, He C, et al. Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching. J Med Chem 2008;51:7882–7888.
   PubMed Web of Science ®Google Scholar
• Nieto Y. DNA-binding agents. Cancer Chemother. Biol Response Modif 2005;22:163–203.
   Google Scholar
• Kolesińska B, Kamiński ZJ. Transformation of Tertiary Amines into alkylating reagents by treatment with 2-chloro-4,6-dimethoxy-1,3,5-triazine. A synthetic application of side-reaction accompanying coupling by means of 4-(4,6-dimethoxy-[1,3,5]triazin-2-yl)-4-methyl-morpholin-4-ium chloride (DMTMM). Pol J Chem 2008;82:2115–2123.
   Google Scholar
• Kolesińska B, Kamiński ZJ. The umpolung of substituent effect in nucleophilic aromatic substitution. A new approach to the synthesis of N,N-disubstituted melamines (triazine triskelions) under mild reaction conditions. Tetrahedron 2009;65:3573–3576.
   Google Scholar
• Zon G. Cyclophosphamide analogues. Prog Med Chem 1982;19:205–246.
   PubMedGoogle Scholar
• Preussmann R, Schneider H, Epple F. Identification of alkylating agents. II. Identification of different classes of alkylating agents by a modification of the color reaction with 4-(4-nitrobenzyl)-pyridine (NBP). Arzneimittelforschung 1969;19:1059–1073.
   PubMed Web of Science ®Google Scholar